308 related articles for article (PubMed ID: 29226596)
21. Cardiotoxicity of oncological treatment in children.
Kucharska W; Negrusz-Kawecka M; Gromkowska M
Adv Clin Exp Med; 2012; 21(3):281-8. PubMed ID: 23214190
[TBL] [Abstract][Full Text] [Related]
22. Cardiac complications in cancer treatment - A review.
Li X; Liu M; Sun R; Zeng Y; Chen S; Zhang P
Hellenic J Cardiol; 2017; 58(3):190-193. PubMed ID: 28011332
[TBL] [Abstract][Full Text] [Related]
23. Provision and Clinical Utility of Cardio-Oncology Services for Detection of Cardiac Toxicity in Cancer Patients.
Gujral DM; Lloyd G; Bhattacharyya S
J Am Coll Cardiol; 2016 Mar; 67(12):1499-1500. PubMed ID: 27012411
[No Abstract] [Full Text] [Related]
24. [Cardiotoxicity of antineoplastic drugs].
Drzewoski J; Kasznicki J
Acta Haematol Pol; 1992; 23(2):79-86. PubMed ID: 1488864
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of cardiotoxicity induced by anthracyclines.
Elliott P
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
[TBL] [Abstract][Full Text] [Related]
26. Cardiotoxicity.
Brana I; Tabernero J
Ann Oncol; 2010 Oct; 21 Suppl 7():vii173-9. PubMed ID: 20943611
[TBL] [Abstract][Full Text] [Related]
27. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Zamorano JL; Lancellotti P; Rodriguez Muñoz D; Aboyans V; Asteggiano R; Galderisi M; Habib G; Lenihan DJ; Lip GY; Lyon AR; Lopez Fernandez T; Mohty D; Piepoli MF; Tamargo J; Torbicki A; Suter TM; Zamorano JL; Aboyans V; Achenbach S; Agewall S; Badimon L; Barón-Esquivias G; Baumgartner H; Bax JJ; Bueno H; Carerj S; Dean V; Erol Ç; Fitzsimons D; Gaemperli O; Kirchhof P; Kolh P; Lancellotti P; Lip GY; Nihoyannopoulos P; Piepoli MF; Ponikowski P; Roffi M; Torbicki A; Vaz Carneiro A; Windecker S; ; ;
Eur J Heart Fail; 2017 Jan; 19(1):9-42. PubMed ID: 27565769
[No Abstract] [Full Text] [Related]
28. 111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.
de Korte MA; de Vries EG; Lub-de Hooge MN; Jager PL; Gietema JA; van der Graaf WT; Sluiter WJ; van Veldhuisen DJ; Suter TM; Sleijfer DT; Perik PJ
Eur J Cancer; 2007 Sep; 43(14):2046-51. PubMed ID: 17719768
[TBL] [Abstract][Full Text] [Related]
29. [Cardiologic evaluation of patients undergoing chemotherapy].
Bordoni B; Urbinati S; Tosoni A; Labanti G; Brandes A
Monaldi Arch Chest Dis; 2014 Jun; 82(2):68-74. PubMed ID: 25845089
[TBL] [Abstract][Full Text] [Related]
30. Echocardiography Imaging of Cardiotoxicity.
Kang Y; Scherrer-Crosbie M
Cardiol Clin; 2019 Nov; 37(4):419-427. PubMed ID: 31587783
[TBL] [Abstract][Full Text] [Related]
31. Anthracycline-related cardiotoxicity in childhood cancer survivors.
Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
[TBL] [Abstract][Full Text] [Related]
32. Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.
Avila MS; Siqueira SRR; Ferreira SMA; Bocchi EA
Methodist Debakey Cardiovasc J; 2019; 15(4):267-273. PubMed ID: 31988687
[TBL] [Abstract][Full Text] [Related]
33. Prevention of anthracycline-induced cardiotoxicity in children: the evidence.
van Dalen EC; Caron HN; Kremer LC
Eur J Cancer; 2007 May; 43(7):1134-40. PubMed ID: 17383867
[TBL] [Abstract][Full Text] [Related]
34. Anthracycline cardiotoxicity.
Menna P; Paz OG; Chello M; Covino E; Salvatorelli E; Minotti G
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S21-36. PubMed ID: 21635149
[TBL] [Abstract][Full Text] [Related]
35. Cancer chemotherapy induces cardiotoxicity by targeting cardiac stem cells.
Li YM; Guo YP; Liu Y
J Cell Mol Med; 2010 Nov; 14(11):2630-2. PubMed ID: 20874720
[TBL] [Abstract][Full Text] [Related]
36. Managing anthracycline-induced cardiotoxicity: beginning with the end in mind.
Salvatorelli E; Menna P; Minotti G
Future Cardiol; 2015 Jul; 11(4):363-6. PubMed ID: 26239550
[No Abstract] [Full Text] [Related]
37. Occult cardiotoxicity in childhood cancer survivors exposed to anthracycline therapy.
Toro-Salazar OH; Gillan E; O'Loughlin MT; Burke GS; Ferranti J; Stainsby J; Liang B; Mazur W; Raman SV; Hor KN
Circ Cardiovasc Imaging; 2013 Nov; 6(6):873-80. PubMed ID: 24097420
[TBL] [Abstract][Full Text] [Related]
38. Cardiotoxicity due to Chemotherapy: the Role of Biomarkers.
Stevens PL; Lenihan DJ
Curr Cardiol Rep; 2015 Jul; 17(7):603. PubMed ID: 26026994
[TBL] [Abstract][Full Text] [Related]
39. Cancer and the heart.
Dobson R; Wright DJ
Br J Gen Pract; 2018 May; 68(670):220-221. PubMed ID: 29700020
[No Abstract] [Full Text] [Related]
40. Anthracycline cardiotoxicity.
Horan PG; McMullin MF; McKeown PP
Eur Heart J; 2006 May; 27(10):1137-8. PubMed ID: 16611672
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
